Dual-layer detector spectral CT for predicting p16 status in head and neck squamous cell carcinoma

被引:1
作者
Li, Zhijun [1 ,2 ,3 ,4 ]
Ye, Lu [1 ,2 ,3 ,4 ]
Xiao, Jianyu [1 ,2 ,3 ,4 ]
Lu, Xiaomei [5 ]
Ye, Zhaoxiang [1 ,2 ,3 ,4 ]
机构
[1] Tianjin Med Univ, Dept Radiol, Canc Inst & Hosp, Tianjin, Peoples R China
[2] Tianjin Med Univ Canc, Natl Clin Res Ctr Canc, Inst & Hosp, Tianjin, Peoples R China
[3] Tianjins Clin Res Ctr Canc, Tianjin, Peoples R China
[4] Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China
[5] Philips Healthcare, CT Clin Sci CT, Shenyang, Peoples R China
关键词
Head and neck squamous cell carcinoma; Spectral CT; HPV; p16; Quantitative analysis; HUMAN-PAPILLOMAVIRUS; SURVIVAL;
D O I
10.1007/s42058-023-00123-y
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
BackgroundHPV-positive head and neck squamous cell carcinoma (HNSCC) differs from HPV-negative HNSCC in clinical features, biological behavior, pathological manifestations, cytogenetics and tend to have better outcome. Immunohistochemical (IHC) p16 staining is highly sensitive for HPV status exam, but has a certain probability of false positives, and the accurate result of p16 expression could be challenging due to the limitation of the biopsy location and quantity. As a non-invasive approach, dual-layer detector spectral CT (DLSCT) provides multi-parameter quantitative analysis, which could help better reflect the changes of tumor characteristics. Hence, this study aimed to evaluate the spectral-derived differences between the p16( +) and p16(-) group of HNSCC so as to explore the application in preoperative diagnosis in differentiating the p16 expression status of HNSCC.Materials and methodsThe spectral data of 35 patients with biopsy confirmed HNSCC were retrospectively analyzed and compared between p16( +) (n = 11) and p16(-) (n = 25) group. All statistical analyses were performed on SPSS v26.0.ResultsEffective atomic number (Zeff), slope value of virtual monoenergetic image (VMI), and normalized iodine density (NID) of p16( +) group were all significantly lower than p16(-) group (8.36 (8.24, 8.42) vs. 8.57 (8.38, 8.85), 2.45 (2.22, 2.64) vs. 3.06 (2.50, 3.82), 0.43 & PLUSMN; 0.09 vs. 0.55 & PLUSMN; 0.14, respectively) (p < 0.05). Besides, NID showed a good ability to discriminate p16(-) HNSCC from p16( +) HNSCC (AUC = 0.788) with a threshold value of 0.495.ConclusionDLSCT could be helpful for the differentiation of p16 expression in HNSCC.
引用
收藏
页码:116 / 121
页数:6
相关论文
共 50 条
  • [41] The Application of Dual-layer Spectral Detector CT in Abdominal Vascular Imaging
    Lai, Lu-Yao
    Jiang, Ying
    Shu, Jian
    CURRENT MEDICAL IMAGING, 2023, 19 (14) : 1609 - 1615
  • [42] p16 expression in cutaneous squamous cell carcinoma of the head and neck is not associated with integration of high risk HPV DNA or prognosis
    Satgunaseelan, Laveniya
    Chia, Noel
    Suh, Hyerim
    Virk, Sohaib
    Ashford, Bruce
    Lum, Trina
    Ranson, Marie
    Clark, Jonathan
    Gupta, Ruta
    PATHOLOGY, 2017, 49 (05) : 494 - 498
  • [43] p16 status and interval neck dissection findings after a 'clinically complete response' to chemoradiotherapy in oropharyngeal squamous cell carcinoma
    Miah, M. S.
    Spielmann, P.
    White, S. J.
    Kennedy, C.
    Kernohan, N.
    Mountain, R. E.
    Cassasola, R.
    Mahendran, S.
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2015, 129 (08) : 801 - 806
  • [44] Automated RNA In Situ Hybridization for 18 High Risk Human Papilloma Viruses in Squamous Cell Carcinoma of the Head and Neck: Comparison With p16 Immunohistochemistry
    Drumheller, Bradley
    Cohen, Cynthia
    Lawson, Diane
    Siddiqui, Momin T.
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2019, 27 (02) : 160 - 164
  • [45] The Clinical Relevance of p16 and p53 Status in Patients with Squamous Cell Carcinoma of the Vulva
    Barlow, Ellen L.
    Lambie, Neil
    Donoghoe, Mark W.
    Naing, Zin
    Hacker, Neville F.
    JOURNAL OF ONCOLOGY, 2020, 2020
  • [46] Integrated analysis of lncRNA-associated ceRNA network in p16-positive and p16-negative head and neck squamous cell carcinoma
    Yang, Yifan
    Feng, Ling
    Wang, Ru
    Ma, Hongzhi
    He, Shizhi
    Fang, Jugao
    MEDICINE, 2022, 101 (33) : E26120
  • [47] CDK4/6 inhibitors in P16/HPV16-negative squamous cell carcinoma of the head and neck
    Billard-Sandu, Camelia
    Tao, Yun-Gan
    Sablin, Marie-Paule
    Dumitrescu, Gabriela
    Billard, David
    Deutsch, Eric
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2020, 277 (05) : 1273 - 1280
  • [48] p16 Positive Oropharyngeal Squamous Cell Carcinoma: An Entity With a Favorable Prognosis Regardless of Tumor HPV Status
    Lewis, James S., Jr.
    Thorstad, Wade L.
    Chernock, Rebecca D.
    Haughey, Bruce H.
    Yip, James H.
    Zhang, Qin
    El-Mofty, Samir K.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2010, 34 (08) : 1088 - 1096
  • [49] Human papillomavirus and p16 immunostaining, prevalence and prognosis of squamous carcinoma of unknown primary in the head and neck region
    Ren, Jianjun
    Yang, Wen
    Su, Jie
    Ren, Xue
    Fazelzad, Rouhi
    Albert, Tiong
    Habbous, Steven
    Goldstein, David P.
    de Almeida, John R.
    Hansen, Aaron
    Jang, Raymond
    Bratman, Scott, V
    Hope, Andrew
    Chen, Ruiqi
    Wang, Jing
    Xu, Yang
    Cheng, Danni
    Zhao, Yu
    Xu, Wei
    Liu, Geoffrey
    INTERNATIONAL JOURNAL OF CANCER, 2019, 145 (06) : 1465 - 1474
  • [50] p16 Not a Prognostic Marker for Hypopharyngeal Squamous Cell Carcinoma
    Wilson, David D.
    Rahimi, Asal S.
    Saylor, Drew K.
    Stelow, Edward B.
    Jameson, Mark J.
    Shonka, David C., Jr.
    Reibel, James F.
    Levine, Paul A.
    Read, Paul W.
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2012, 138 (06) : 556 - 561